IM Cannabis (NASDAQ:IMCC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does IM Cannabis (IMCC) operate in?

IM Cannabis is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

IM Cannabis Stock (NASDAQ: IMCC) stock price, news, charts, stock research, profile.

Open	$2.35
Close	$2.31
Volume / Avg.	6.46K / 28.78K
Day Range	$2.22 - $2.35
52 Wk Range	1.13 - 8.10
Market Cap	$5.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	0.71%
Days to Cover	1

Recent News

IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY

The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023. The company also reported a 129% year-over-year increase in IMC Germany sales to CA$3.5 million, making up 24% of the entire company revenue.

Jelena Martinovic

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024. cbdMD, Inc. (NYSE: YCBD) said it will host a conference call at 4:20 pm Eastern Time, on Wednesday, Aug. 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress. Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) its second quarter 2024 financial results will be released after market close on Monday, Aug. 26, 2024. The company will host a conference call to discuss the results and provide an operational update and recap of achievements on Tuesday, Aug. 27, 2024. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, Aug. 13, 2024, before market open. The company will host a conference call to discuss its results with details the same day at 8:00 am Eastern Time.

Jelena Martinovic

European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s recent decriminalization have ignited optimism within the sector.

Nicolás Jose Rodriguez

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy IM Cannabis (IMCC) stock?

You can purchase shares of IM Cannabis (NASDAQ:IMCC) through any online brokerage.

View our list of the best stock brokerages

Who are IM Cannabis (IMCC) competitors?

There are no as such competitors for IM Cannabis.

What is the forecast, or price target, for IM Cannabis (IMCC) stock?

IM Cannabis has a consensus price target of $8.00.

What is the current price for IM Cannabis (IMCC)?

The stock price for IM Cannabis (NASDAQ: IMCC) is $2.43 last updated September 4, 2024 at 4:16 PM EDT.

Does IM Cannabis (IMCC) pay a dividend?

There are no upcoming dividends for IM Cannabis.

When is IM Cannabis (NASDAQ:IMCC) reporting earnings?

IM Cannabis’s Q3 earnings are confirmed for Monday, November 11, 2024.

Is IM Cannabis (IMCC) going to split?

There is no upcoming split for IM Cannabis.

What sector and industry does IM Cannabis (IMCC) operate in?

IM Cannabis is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

Gain an Edge Using Pro's Market Moving News Breaks — 50% OFF